Standardized tumor rates for chronic bioassays

Area of Science:

• Toxicology
• Risk Assessment
• Biostatistics

Background:

• Crude tumor proportions in carcinogenicity bioassays can be biased by differential mortality.
• Previous methods adjusted tumor rates by removing competing causes of death.

Purpose of the Study:

• To propose a novel method for adjusting tumor rates in carcinogenicity bioassays.
• To account for natural mortality due to competing risks, reflecting lifetime tumor incidence.
• To improve the accuracy of low-dose extrapolation in risk analysis.

Main Methods:

• Extending the Farmer et al. (1982) approach.
• Calculating standardized tumor rates by including natural mortality.
• Summating adjusted age-specific probabilities of dying with a tumor and surviving with a tumor.

Main Results:

• The proposed method provides adjusted tumor rates that reflect lifetime or near-lifetime tumor incidences.
• This approach explicitly includes natural mortality, unlike previous methods.
• Standardized rates offer a more accurate basis for risk assessment.

Conclusions:

• The proposed method offers a more robust approach to risk assessment by accounting for differential mortality.
• This technique enhances the accuracy of low-dose extrapolation for carcinogenicity studies.
• Explicitly including competing risks provides a more realistic estimation of tumor incidence.